CHEMOTHERAPY-ONLY TREATMENT IN LOW AND STANDARD RISK MATURE B-CELL NON-HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS: POOLED ANALYSIS OF THE FAB/LMB96 AND LMB2001 STUDIES

IF 2.2 4区医学 Q3 HEMATOLOGY

Leukemia research Pub Date : 2025-09-01 DOI:10.1016/j.leukres.2025.107966

V Minard-Colin, A Aupérin, Burke Gaa, M Taj, F Meyer - Wentrup, M de Ville de Goyet, O Smith, S Haouy, S Ducassou, CM Bollard, A Leruste, T Molina, RR Miles, TG Gross, S Alexander, C Patte, MS Cairo

引用次数: 0

查看原文本刊更多论文

仅化疗治疗儿童和青少年低风险和标准风险成熟b细胞非霍奇金淋巴瘤：fab / lmb96和lmb2001研究的汇总分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.